1.0 2026-04-03 00:09:14 UTC 2026-08-22 05:01:08 UTC Apixaban SmallMolecule Apixaban is an organic compound with the formula C25H25N5O4 and an average molecular weight of 459.51 g/mol. Apixaban belongs to the phenylpiperidines, a subclass of piperidines within the organic compounds. It is classified as an organoheterocyclic compound. This substance acts as an inhibitor of Coagulation factor X (F10). The compound is found in or released from two recorded sources: amplifiers within electrical and electronic equipment, and antithrombotic agents within healthcare, pharmaceuticals, and veterinary products. The recorded route of exposure is oral. Regarding health effects, apixaban is used as a treatment for thrombosis (PMC9387011) and has a therapeutic effect on ischemic stroke (PMC12299637). Human Neurotoxin 1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine- 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide 1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- 3-carboxylic acid amide 3917013 3Z9Y7UWC1J 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide apixab??n Apixaban Apixaban (JAN/USAN/INN) Apixaban (USAN/INN) Apixaban BMS-562247-01 Apixaban(BMS-562247-01) apixabanum BMS 562247-01 BMS-562247-01 BMS-562247|Eliquis® BMS562247-01 diketo-gulonic acid Eliquis® GG2 OO 1750000 S1593_Selleck Sodium malonate dibasic UNII-3Z9Y7UWC1J UNII:3Z9Y7UWC1J [503612-47-3] C25H25N5O4 459.506 459.190654 503612-47-3 COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32) QNZCBYKSOIHPEH-UHFFFAOYSA-N Detected and Not Quantified Apixaban Action Pathway (new) SMP0126437 Apixaban Drug Metabolism Action Pathway SMP0144055 logp 1.83 average_mass 459.506 ChemAxon mono_mass 459.190654 ChemAxon smiles COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O ChemAxon formula C25H25N5O4 ChemAxon inchi InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32) ChemAxon inchikey QNZCBYKSOIHPEH-UHFFFAOYSA-N ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f7225b05790> DB06605 10182969 8358471 BE0000216